CCR2 and glioblastoma: Analyzing the expression level of CCR2 within GBM patient samples using the TCGA database, we found that 51.5% of all patient specimens show regulated CCR2 expression (19.3% up-regulation and 32.2% down-regulation; Figure 1a).